Log in to save to my catalogue

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a gl...

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a gl...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6436818

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

About this item

Full title

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Author / Creator

Horwitz, Steven , O'Connor, Owen A , Advani, Ranjana , Rossi, Giuseppe , Kim, Won Seog , Illés, Árpád , Tobinai, Kensei , Yeh, Su-Peng , Shustov, Andrei , Yuen, Sam , Iyer, Swaminathan , Hua, Zhaowei , Little, Meredith , Rao, Shangbang , Woolery, Joseph , Manley, Thomas , Aboulafia, David , Bartlett, Nancy , Belada, David , Yehuda, Dina Ben , Benedetti, Fabio , Bordessoule, Dominique , Chang, Hung , Cheong, June Weon , Choi, Ilseung , Colita, Andrei , Congui, Angela Giovanna , Dang, Nam , Davison, Kelly , de Guibert, Sophie , Delwail, Vincent , di Raimondo, Francesco , Do, Young Rok , Domingo, Eva , Douvas, Michael , Dreyling, Martin , Fay, Keith , Ferrero, Silvia Fernandez , Flinn, Ian Winchester , Forero-Torres, Andres , Friedberg, Jonathan , Fukuhara, Noriko , Garcia-Marco, Jose , Cruz, Jorge Gayoso , Gurion, Ronit , Christensen, Jacob Haaber , Hajek, Roman , Hatake, Kiyohiko , Horowitz, Netanel , Illes, Arpad , Illidge, Tim , Ishizawa, Kenichi , Islas-Ohlmayer, Miguel , Jacobsen, Eric , Janakiram, Murali , Jurczak, Wojciech , Kaminski, Mark , Kato, Koji , Kim, Won Seog , Iyer, Swaminathan , Kuo, Ching-Yuan , Lazaroiu, Mihaela Cornelia , Lee, Jong-Seok , Lennard, Anne , LaRosee, Paul , Levi, Itai , Link, Brian , Maisonneuve, Herve , Maruyama, Dai , Mayer, Jiri , Mocikova, Heidi , Morra, Enrica , Morschhauser, Franck , Munoz, Javier , Nagai, Hirokazu , Opat, Stephen , Pettengell, Ruth , Pezzutto, Antonio , Pfreundschuh, Michael , Pro, Barbara , Reyes, Ruben , Izquierdo, Antonia Rodriguez , Rossi, Giuseppe , Ruan, Jia , Salles, Gilles , Sarriera, Jose , Shibayama, Hirohiko , Shustov, Andrei , Suh, Cheolwon , Sureda, Anna , Tanimoto, Mitsune , Taniwaki, Masafumi , Tilly, Herve , Tsukamoto, Norifumi , Wilhelm, Martin , Yamamoto, Kazuhito , Yeh, Su-Peng , Yun, Hwan Jung , Zain, Jasmine , Zinzani, Pier Luigi and ECHELON-2 Study Group

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2019-01, Vol.393 (10168), p.229-240

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Based on the encouraging activity and manageable safety profile observed in a phase 1 study, the ECHELON-2 trial was initiated to compare the efficacy and safety of brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) versus cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) for the treatment of CD30-positive pe...

Alternative Titles

Full title

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Authors, Artists and Contributors

Author / Creator

Horwitz, Steven
O'Connor, Owen A
Advani, Ranjana
Rossi, Giuseppe
Kim, Won Seog
Illés, Árpád
Tobinai, Kensei
Yeh, Su-Peng
Shustov, Andrei
Yuen, Sam
Iyer, Swaminathan
Hua, Zhaowei
Little, Meredith
Rao, Shangbang
Woolery, Joseph
Manley, Thomas
Aboulafia, David
Bartlett, Nancy
Belada, David
Yehuda, Dina Ben
Benedetti, Fabio
Bordessoule, Dominique
Chang, Hung
Cheong, June Weon
Choi, Ilseung
Colita, Andrei
Congui, Angela Giovanna
Dang, Nam
Davison, Kelly
de Guibert, Sophie
Delwail, Vincent
di Raimondo, Francesco
Do, Young Rok
Domingo, Eva
Douvas, Michael
Dreyling, Martin
Fay, Keith
Ferrero, Silvia Fernandez
Flinn, Ian Winchester
Forero-Torres, Andres
Friedberg, Jonathan
Fukuhara, Noriko
Garcia-Marco, Jose
Cruz, Jorge Gayoso
Gurion, Ronit
Christensen, Jacob Haaber
Hajek, Roman
Hatake, Kiyohiko
Horowitz, Netanel
Illes, Arpad
Illidge, Tim
Ishizawa, Kenichi
Islas-Ohlmayer, Miguel
Jacobsen, Eric
Janakiram, Murali
Jurczak, Wojciech
Kaminski, Mark
Kato, Koji
Kim, Won Seog
Iyer, Swaminathan
Kuo, Ching-Yuan
Lazaroiu, Mihaela Cornelia
Lee, Jong-Seok
Lennard, Anne
LaRosee, Paul
Levi, Itai
Link, Brian
Maisonneuve, Herve
Maruyama, Dai
Mayer, Jiri
Mocikova, Heidi
Morra, Enrica
Morschhauser, Franck
Munoz, Javier
Nagai, Hirokazu
Opat, Stephen
Pettengell, Ruth
Pezzutto, Antonio
Pfreundschuh, Michael
Pro, Barbara
Reyes, Ruben
Izquierdo, Antonia Rodriguez
Rossi, Giuseppe
Ruan, Jia
Salles, Gilles
Sarriera, Jose
Shibayama, Hirohiko
Shustov, Andrei
Suh, Cheolwon
Sureda, Anna
Tanimoto, Mitsune
Taniwaki, Masafumi
Tilly, Herve
Tsukamoto, Norifumi
Wilhelm, Martin
Yamamoto, Kazuhito
Yeh, Su-Peng
Yun, Hwan Jung
Zain, Jasmine
Zinzani, Pier Luigi
ECHELON-2 Study Group

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6436818

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6436818

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(18)32984-2

How to access this item